1379P Margetuximab (M) with retifanlimab (R) in HER2+, PD-L1+ 1st-line unresectable/metastatic gastroesophageal adenocarcinoma (GEA): MAHOGANY cohort A

Daniel V.T. Catenacci, H. Park, Byoung Yong Shim, S.T. Kim, D-Y. Oh, Alexander I. Spira, Susanna V. Ulahannan, Eric J. Avery, Patrick M. Boland, Joseph Chao, Hyun Cheol Chung, F. Gardner, S.J. Klempner, Kyung-Woo Lee, Sang Cheul Oh, Julio A. Peguero, Mohamad Bassam Sonbol, Jichao Sun, Minori Koshiji Rosales, Y-K. Kang